Refer A Patient

Request An Appointment

Neurology

VYEPTI

VYEPTI (eptinezumab-jjmr) is a calcitonin-gene-related peptide antagonist (CGRP) inhibitor that is used to prevent migraines in adults.
Infusion or injection therapy referral
What it treats Migraines
Prescribed by Neurologists
How it’s administered Intravenous (IV) infusion
Frequency Every three months
Length of treatment 30 minutes to two hours

About This Therapy

VYEPTI (eptinezumab-jjmr) is a calcitonin-gene-related peptide antagonist (CGRP) inhibitor that is used to prevent migraines in adults. VYEPTI was approved for use by the Food and Drug administration (FDA) in February 2020 and became available in April.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

VYEPTI REFERRAL FORM

VYEPTI REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.
REFERRAL FORM →

Ready to refer a patient for VYEPTI

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.